Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and oxaliplatin, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. It
is not yet known whether giving both of these drugs on the same day is more effective than
giving them on different days.
PURPOSE: This randomized phase III trial is studying two different schedules of gemcitabine
and oxaliplatin to compare how well they work in treating patients with metastatic pancreatic
cancer.
Phase:
Phase 3
Details
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)